Welcome to the Animal Pharm Hall of Fame
Entrants to the Hall of Fame must have provided game-changing commitment to the animal health industry. This applies to company leaders, R&D innovators and disruptive forward-thinkers.
The Animal Pharm Hall of Fame commends outstanding work from key players within the animal health industry.
The Hall of Fame is open to people from any size of animal health company – from the smallest start-up to the biggest player. Below are the current members of the Hall of Fame in alphabetical order. Animal Pharm aims to add multiple entrants to the Hall of Fame every year.
Send your suggestions for new members to Animal Pharm's editor Joseph Harvey at email@example.com.
Juan Ramón Alaix
Juan Ramón Alaix is perhaps the most influential person in the animal health sector, as he guides the industry's largest player.
The Zoetis chief executive has been instrumental in transforming the company from a segment of Pfizer to a dynamic standalone animal health multinational with around 9,000 employees. Mr Alaix fronted Zoetis as it went public and has since established himself as one of the most recognized faces in the industry.
From an Animal Pharm perspective, he is an open and engaging chief executive. His presentations on analyst calls or at investor conferences and animal health forums show his depth of knowledge on a whole host of subjects related to animal health, agriculture, finance and economics.
He is highly thought of by his colleagues at Zoetis and also by those at competitor companies – a sign of the respect he holds in animal health.
Originally from Barcelona, Mr Alaix graduated in economics from the Universidad de Madrid. He then embarked on a career that has, so far, provided him with 35 years of experience in finance, sales and management. This includes 21 years in the pharmaceutical industry.
In the 1990s, he held general management roles with Rhône-Poulenc Rorer in Spain and Belgium, before becoming country president of Spain for Pharmacia in 1998. He then joined Pfizer from Pharmacia in 2003 as a regional president. Before heading up Zoetis, he was the president of Pfizer Animal Health from 2006.
Aside from these roles, Mr Alaix completed a two-year term as president of the International Federation for Animal Health (now known as HealthforAnimals) in 2013. He continues to serve as a member of the HealthforAnimals board and executive committee.
Dr George Gunn
George Gunn – the founder and chief executive of Stonehaven Consulting – was a previous winner of Animal Pharm's Lifetime Achievement Award for his contribution across several roles in the sector, including chief executive of Novartis Animal Health.
Over the course of his career, Dr Gunn has held several roles that have had a significant impact on animal health.
Originally from the Shetland Islands in Scotland, Dr Gunn worked as a veterinary surgeon for nine years after graduating with a bachelor of veterinary medicine and surgery degree from the Royal (Dick) School of Veterinary Studies in the UK. He graduated with a diploma in veterinary state medicine from the same school.
He worked with the UK's Ministry of Agriculture, Fisheries and Food (now known as the Department for Environment, Food & Rural Affairs) in the 1970s and 1980s. He first featured in Animal Pharm in 1996, when he was appointed director of Janssen Animal Health in the UK.
Before joining Novartis in 2003, Dr Gunn was president of Pharmacia Animal Health and previously spent more than 15 years in positions of increasing responsibility in various companies, including Coopers Animal Health and Pharmacia.
In 2015, Dr Gunn retired from his position as division head for Novartis Animal Health. He had been at the helm of Novartis Animal Health since 2004. Before taking this position, he held the roles of: head of Novartis Animal Health, North America; division head, Novartis Consumer Health; and head of Corporate Responsibility.
During his career, Dr Gunn was also elected the president of the International Federation of Animal Health (IFAH) in 2006. In 2015, he was presented a lifetime achievement award by the organization (now called HealthforAnimals). Dr Gunn was awarded the accolade for his work as IFAH's president. In this role he was re-elected, even though the position is usually only allocated for one two-year term.
Virbac's former chairman Éric Marée is another previous winner of the Lifetime Achievement Award.
Mr Marée spent over 18 years at Virbac after becoming the company's chairman in 1999. During Mr Marée's tenure, Virbac climbed from 16th in Animal Pharm's industry rankings in 2000 with sales of around $300 million, to ninth position in 2016 with revenues more than tripling.
His leadership at Virbac has seen the company grow into an international presence with a highly diversified product portfolio. Now, the firm records more revenues in international markets than it does in Europe.
Additionally, Virbac's workforce has nearly doubled in size while Mr Marée has been at the helm. Today, the business has just under 5,000 employees (with more than 80% outside of France).
After graduating from the HEC School of Management in Paris, he gained an MBA at Cornell University's Samuel Curtis Johnson Graduate School of Management in 1978.
Mr Marée worked as a consultant for McKinsey (1981-1989) before embarking on a career in management across French healthcare. Previously, he held senior positions with Rhône-Poulenc Rorer (1990-1994) and Roche (1994-1999).
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.